- cafead   Jul 29, 2024 at 11:12: AM
via Boehringer Ingelheim is investing again in immuno-oncology, announcing Monday a deal to acquire the San Diego-based biotechnology startup Nerio Therapeutics and its slate of preclinical drug candidates.
article source
article source